Nasdaq
INMB
INmune Bio Inc.
- Health Care
- Listed 2019
- 1 day
- +0.5%
- 1 month
- +9.8%
- 1 year
- −30.8%
$1.91 · Mkt cap $50.8M
At the 6 Aug 2026 close
Nasdaq
INmune Bio Inc.
$1.91 · Mkt cap $50.8M
At the 6 Aug 2026 close
INmune Bio Inc. trades under the ticker INMB on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2019. Its market capitalisation is $50.8M. The last closing price was $1.91, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −30.8%, and +9.8% over the past month. Returns are price returns and exclude dividends.
This page exists because INMB is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.